{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:16:00Z","timestamp":1791285360915,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Zeitschrift f\u00fcr Medizinische Physik"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.zemedi.2011.01.006","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T22:04:33Z","timestamp":1304373873000},"page":"250-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Dosimetry prior to I-131-therapy of benign thyroid disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Heribert","family":"H\u00e4nscheid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"La\u00dfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Reiners","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.zemedi.2011.01.006_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1160\/nukmed-0283","article-title":"Procedure guideline for radioiodine test (Version 3)","volume":"46","author":"Dietlein","year":"2007","journal-title":"Nuklearmedizin."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1160\/nukmed-0287","article-title":"Guideline for radioiodine therapy for benign thyroid diseases (version 4)","volume":"46","author":"Dietlein","year":"2007","journal-title":"Nuklearmedizin."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0015","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1007\/s00259-010-1536-8","article-title":"EANM procedure guidelines for therapy of benign thyroid disease","volume":"37","author":"Stokkel","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/105072501750302877","article-title":"The use of three-dimensional ultrasound for thyroid volumetry","volume":"11","author":"Schl\u00f6gl","year":"2001","journal-title":"Thyroid."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0025","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s002590000348","article-title":"Does thyroid stunning exist? A model with benign thyroid disease","volume":"27","author":"Sabri","year":"2000","journal-title":"Eur J Nucl Med."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.zemedi.2011.04.006","article-title":"Follow-up on thyroidal uptake after radioiodine therapy - how robust is the peri-therapeutic dosimetry?","volume":"21","author":"Eschner","year":"2011","journal-title":"Z Med Phys."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1623910","article-title":"Concept and validation of a simple model of the intrathyroidal iodine kinetics","volume":"43","author":"Rink","year":"2004","journal-title":"Nuklearmedizin."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0040","first-page":"260","article-title":"Dosage determination with radioactive isotopes; practical considerations in therapy and protection","volume":"59","author":"Marinelli","year":"1948","journal-title":"Am J Roentgenol Radium Ther."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0045","first-page":"1632","article-title":"Optimized dose planning of radioiodine therapy of benign thyroidal diseases","volume":"34","author":"Bockisch","year":"1993","journal-title":"J Nucl Med."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0050","first-page":"A 128","article-title":"Aktivit\u00e4tsbestimmung vor Radiojodtherapie der Schilddr\u00fcse - ein Vorschlag zur Minimierung von Aufwand und Fehler","volume":"32","author":"H\u00e4nscheid","year":"1993","journal-title":"Nuklearmedizin."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0055","first-page":"201","volume":"31","author":"Kobe","year":"2010","journal-title":"Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I? Nucl Med Commun."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0060","first-page":"473","article-title":"Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism","volume":"18","author":"J\u00f6nsson","year":"2003","journal-title":"Cancer Biother Radiopharm."},{"key":"10.1016\/j.zemedi.2011.01.006_bib0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00006231-200607000-00003","article-title":"Optimized radioiodine therapy for Graves\u2019 disease: two MIRD-based models for the computation of patient-specific therapeutic 131I activity","volume":"27","author":"Carlier","year":"2006","journal-title":"Nucl Med Commun."}],"container-title":["Zeitschrift f\u00fcr Medizinische Physik"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939388911000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939388911000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:01:09Z","timestamp":1760544069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939388911000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0939388911000080"],"URL":"https:\/\/doi.org\/10.1016\/j.zemedi.2011.01.006","relation":{},"ISSN":["0939-3889"],"issn-type":[{"value":"0939-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetry prior to I-131-therapy of benign thyroid disease","name":"articletitle","label":"Article Title"},{"value":"Zeitschrift f\u00fcr Medizinische Physik","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.zemedi.2011.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}